The importance of rigorous methods in observational comparative effectiveness studies of rare diseases: comment on the article by Ruperto et al
Arthritis Rheumatol
.
2022 May;74(5):912-913.
doi: 10.1002/art.42047.
Epub 2022 Mar 31.
Authors
Yukiko Kimura
1
,
Mei-Sing Ong
2
,
George Tomlinson
3
,
Sarah Ringold
4
,
Laura E Schanberg
5
,
Brian M Feldman
6
,
Anne Dennos
7
,
Vincent Del Gaizo
8
,
Katherine L Murphy
9
,
Marc Natter
10
Affiliations
1
Joseph M. Sanzari Children's Hospital, and Hackensack Meridian School of Medicine, Hackensack, NJ.
2
Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, MA.
3
University of Toronto, Toronto, Ontario, Canada.
4
Seattle Children's Hospital, Seattle, WA.
5
Duke University Medical Center and Childhood Arthritis and Rheumatology Research Alliance, Durham, NC.
6
The Hospital for Sick Children, Toronto, Ontario, Canada.
7
Duke Clinical Research Institute, Durham, NC.
8
Childhood Arthritis and Rheumatology Research Alliance, Milwaukee, WI.
9
Louisiana State Department of Health, New Orleans, LA.
10
Boston Children's Hospital Massachusetts General Hospital and Harvard Medical School, Boston, MA.
PMID:
34905294
DOI:
10.1002/art.42047
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Rare Diseases*
Research*